Peter Radovich - Mar 25, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
PRESIDENT AND COO
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Mar 25, 2024
Transactions value $
-$111,017
Form type
4
Date filed
3/25/2024, 05:41 PM
Previous filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$111K -4.3K -12.92% $25.80 29K Mar 25, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $25.80, and the range of prices were between $25.80 and $25.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.